PremiumCompany AnnouncementsGlucotrack Reports Transformative Year with Clinical Advances GlucoTrack Advances with Clinical Trials and Funding Boost GlucoTrack to Present Data on New Glucose Monitoring System PremiumThe FlyGlucoTrack prices offering of 2.6M shares of common stock at $1.15 GlucoTrack Announces Reverse Stock Split and Clinical Study Success GlucoTrack announces completion of first in human clinical study of CGM PremiumCompany AnnouncementsGlucoTrack Strengthens Leadership with New CFO Appointment GlucoTrack appoints Wulff as Chief Financial Officer GlucoTrack Achieves ISO13485:2016 Certification for CBGM